Surveying the Current State
of Biosimilars  
On Tuesday, December 10, during the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada, in an educational session titled "The Rise of the Biosimilars: Increasing Use on a Broad Scale," pharmacy professionals from health systems in Colorado and Tennessee assessed the current state of biosimilar medications from the regulatory and clinical perspectives. Read more.

Sessions Address Antimicrobial Stewardship
A pair of educational sessions presented by Brandon Hill, PharmD, BCPS, University of Virginia Health System (above right) on Sunday, December 8, 2019, at the 2019 ASHP Midyear Meeting & Exhibition assessed the critical mission of ensuring that hospital-acquired infection rates remain as low as possible, including a tutorial on how to prepare new pharmacists for vital antimicrobial leadership roles and surveying technologies to quickly identify hospital infections. Read more.

Poster Points to Superior Stability of Omeprazole Suspension Kit
Remonica Jackson, BS, MS, PharmD candidate, East Tennessee State University (above right), delivered a poster presentation during the 2019 ASHP Midyear Clinical Meeting & Exhibition on Monday, December 9, analyzing the comparative stability of compounded omeprazole suspension versus a commercial omeprazole kit when stored in oral syringes under refrigerated conditions. Read more.

FDA Updates Attendees on
Compounding Policies
On Tuesday morning during the 2019 ASHP Midyear Clinical Meeting & Exhibition, Tracy Rupp, PharmD, MPH, RD, consumer safety officer, FDA, Silver Spring, Maryland, and Marci Kiester, PharmD, MSHS, RAC, senior policy analyst, FDA, reviewed the FDA's 2019 compounding policy priorities, discussing recent compounding policy documents while reviewing current good manufacturing practice and the agency's proposed policies for compounders registered as outsourcing facilities. Read more.